According to the new research report published by Precedence Research, titled “MicroRNA Market (By Products: Instruments, Consumables; By Services: Service Type, Specimen; By Application: Cancer, Infectious Diseases Immunological Disorder, Cardiovascular Disease, Neurological Disease, Others; By End Use: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Other end-users) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032 (By Product: Traditional, Advanced; By Application: Pottery, Tiles, Abrasives, Sanitary wave, Bricks & pipes, Others; By End User: Medical, Industrial, Building & Construction, Others) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032”, the global microRNA market size is expected to be worth around US$ 7,757.01 million by 2032 and is poised to record a yearly growth rate of 20% from 2023 to 2032. The study investigates several elements and their consequences on the growth of the all-wheel drive market.
This report focuses on microRNA market volume and value at the global level, regional level and company level. From a global perspective, this report represents the overall microRNA market size by analysing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, the Middle East & Africa, Latin America, etc.
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2032. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3023
The study also provides important advancements in organic and inorganic growth strategies in the worldwide microRNA market. A lot of corporations are prioritizing new launches, product approvals, and other business expansion techniques. In addition, the report offers profiles of microRNA market firms and market strategies. Furthermore, the research focuses on top industry participants, providing information such as company profiles, components and services offered, recent financial data, and key developments.
MicroRNA Market Report Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 1,503.36 Million |
| Market Size by 2032 | USD 7,757.01 Million |
| Growth Rate from 2023 to 2032 | CAGR of 20% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Products, By Services, By Application, and By End Use |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Also read: Sequencing Reagents Market Size US$ 13.43 Billion by 2032
Market Key Players
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the microRNA market.
Some of the prominent players in the microRNA market include
- Merck KGaA
- QIAGEN
- Thermo Fisher Scientific Inc.
- Synlogic
- GeneCopoeia, Inc
- Horizon Discovery Ltd.
- New England Biolabs
- Quantabio
- NanoString
- BioGenex
- SeqMatic LLC
- Miltenyi Biotec
- Agilent Technologies, Inc
- Promega Corporation
- Abcam plc
- KANEKA CORPORATION
MicroRNA Market Segmentations
By Products
- Instruments
- Consumables
By Services
- Service Type
- Isolation & Purification
- miRNA cDNA Synthesis
- Profiling, Localization, & Quantification
- Functional Analysis
- Real Time PCR
- Microarray
- NGS
- Others
- Specimen
- Whole Blood
- Serum
- Plasma
- FFPE
- Fresh Frozen Tissue
- Others
By Application
- Cancer
- Infectious Diseases
- Immunological Disorder
- Cardiovascular Disease
- Neurological Disease
- Others
By End Use
- Biotechnology & Pharmaceutical Companies
- Academic & Government Research Institutes
- Other end-users
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Report Objectives
- To define, segment, and project the global market size for microRNA market
- To understand the structure of the market by identifying its various sub-segments
- To provide detailed information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To analyse the micro-markets, with respect to individual growth trends, future prospects, and their contributions to the total market
- To project the size of the market and its submarkets, in terms of value, with respect to global. (along with their respective key countries)
- To profile key players and comprehensively analyse their core competencies
- To understand the competitive landscape and identify major growth strategies adopted by players across the globe.
- To analyse the competitive developments such as expansions & investments, new product launches, mergers & acquisitions, joint ventures, and agreements
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on MicroRNA Market
5.1. COVID-19 Landscape: MicroRNA Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global MicroRNA Market, By Products
8.1. MicroRNA Market Revenue and Volume Forecast, by Products, 2023-2032
8.1.1. Instruments
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. Consumables
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global MicroRNA Market, By Services
9.1. MicroRNA Market Revenue and Volume Forecast, by Services, 2023-2032
9.1.1. Service Type
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Specimen
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global MicroRNA Market, By Application
10.1. MicroRNA Market Revenue and Volume Forecast, by Application, 2023-2032
10.1.1. Cancer
10.1.1.1. Market Revenue and Volume Forecast (2020-2032)
10.1.2. Infectious Diseases
10.1.2.1. Market Revenue and Volume Forecast (2020-2032)
10.1.3. Immunological Disorder
10.1.3.1. Market Revenue and Volume Forecast (2020-2032)
10.1.4. Cardiovascular Disease
10.1.4.1. Market Revenue and Volume Forecast (2020-2032)
10.1.5. Neurological Disease
10.1.5.1. Market Revenue and Volume Forecast (2020-2032)
10.1.6. Others
10.1.6.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 11. Global MicroRNA Market, By End Use
11.1. MicroRNA Market Revenue and Volume Forecast, by End Use, 2023-2032
11.1.1. Biotechnology & Pharmaceutical Companies
11.1.1.1. Market Revenue and Volume Forecast (2020-2032)
11.1.2. Academic & Government Research Institutes
11.1.2.1. Market Revenue and Volume Forecast (2020-2032)
11.1.3. Other end-users
11.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 12. Global MicroRNA Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.1.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.1.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.1.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.1.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.1.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.1.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.1.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.1.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.1.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.2.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.2.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.2.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.2.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.2.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.2.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.2.7.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.2.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.7.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.2.8.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.2.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.8.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.3.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.3.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.3.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.3.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.3.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.3.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.3.7.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.3.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.7.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.3.8.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.3.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.8.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.4.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.4.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.4.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.4.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.4.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.4.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.4.7.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.4.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.7.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.4.8.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.4.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.8.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.5.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.5.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.5.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.5.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.5.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.5.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
Chapter 13. Company Profiles
13.1. Merck KGaA
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. QIAGEN
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Thermo Fisher Scientific Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Synlogic
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. GeneCopoeia, Inc
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Horizon Discovery Ltd.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. New England Biolabs
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Quantabio
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. NanoString
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. BioGenex
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global microRNA market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for microRNA are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2023-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
